Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

Alkermes, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Alkermes, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Allergan Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Allergan Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Allergy Therapeutics plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Allergy Therapeutics plc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Alliance Pharma plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Alliance Pharma plc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Alliance Pharmaceutical Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Alliance Pharmaceutical Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Allied Biotech Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Allied Biotech Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Allon Therapeutics, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Allon Therapeutics, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Allos Therapeutics, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Allos Therapeutics, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Alnylam Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Alnylam Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Alpa Laboratories Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Alpa Laboratories Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

AlphaHelix Molecular Diagnostics AB Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

AlphaHelix Molecular Diagnostics AB Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Alseres Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Alseres Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

AlumiFuel Power Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

AlumiFuel Power Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

AMAG Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

AMAG Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Amarillo Biosciences Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Amarillo Biosciences Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 57 pages

Amarin Corporation plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Amarin Corporation plc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Amazon Biotech, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Amazon Biotech, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Ambalal Sarabhai Enterprises Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ambalal Sarabhai Enterprises Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

American Biogenetic Sciences, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

American Biogenetic Sciences, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Amgen Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Amgen, Inc., a biotechnology company, discovers, develops, manufactures, and markets human therapeutics based on advances in cellular and molecular biology. Products The company markets primarily recombinant protein therapeutics in...

November 2026 78 pages

Amicus Therapeutics, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Amicus Therapeutics, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

ProMIS Neurosciences, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ProMIS Neurosciences, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Ampio Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ampio Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Amrutanjan Health Care Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Amrutanjan Health Care Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

AmStem Corp Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

AmStem Corp Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Amsterdam Molecular Therapeutics (AMT) Holding N.V. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Amsterdam Molecular Therapeutics (AMT) Holding N.V. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Amylin Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Amylin Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Anacor Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Anacor Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Anadys Pharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Anadys Pharmaceuticals Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Analytik Jena AG Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Analytik Jena AG Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Anavex Life Sciences Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Anavex Life Sciences Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Angel Biotechnology Holdings PLC Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Angel Biotechnology Holdings PLC Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

AnGes MG Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

AnGes MG Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

AngioGenex, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

AngioGenex, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Angiotech Pharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Angiotech Pharmaceuticals Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Anhui Anke Biotechnology (Group) Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Anhui Anke Biotechnology (Group) Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Anhui Fengyuan Pharmaceutical Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Anhui Fengyuan Pharmaceutical Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Ankur Drugs & Pharma Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ankur Drugs & Pharma Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Anthera Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Anthera Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Anticus International Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Anticus International Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Antigenics, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Antigenics, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Antisense Therapeutics Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Antisense Therapeutics Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Antisoma plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Antisoma plc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Anuh Pharma Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Anuh Pharma Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Anxin-China Holdings Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Anxin-China Holdings Limited Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Aoxing Pharmaceutical Company, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Aoxing Pharmaceutical Company, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

AP Pharma Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

AP Pharma Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Apeloa Company Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Apeloa Company Limited Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Apex Biotechnology Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Apex Biotechnology Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Apex Healthcare Bhd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Apex Healthcare Bhd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Filters

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1